BACKGROUND: Despite clinical reports of poor outcomes, the degree to which resuscitative endovascular balloon occlusion of the aorta (REBOA) exacerbates traumatic brain injury (TBI) is not known. We hypothesized that combined effects of increased proximal mean arterial pressure (pMAP), carotid blood flow (Q carotid ), and intracranial pressure (ICP) from REBOA would lead to TBI progression compared with partial aortic occlusion (PAO) or no intervention.
R
esuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a viable alternative to resuscitative thoracotomy for noncompressible torso hemorrhage (NCTH) by restoring perfusion to proximal vascular beds while arresting downstream hemorrhage.
1,2 REBOA has gained popularity because its minimally invasive nature allows it to be proactively used before hemodynamic collapse. 3 Although adoption of REBOA is increasing, appropriate patient selection remains problematic because no consensus guidelines exist regarding its clinical use. 4, 5 Physicians within the trauma community have hypothesized that REBOA can be detrimental to patients with NCTH and concomitant traumatic brain injuries. 1, 4, [6] [7] [8] [9] Supraphysiologic blood pressure and carotid blood flow (Q carotid ) created by aortic occlusion may worsen cerebral edema, increase intracranial pressure (ICP), or exacerbate intracranial hemorrhage. The mortality rate in brain-injured patients requiring REBOA as a resuscitative adjunct approaches 50% and case reports have demonstrated increased intracranial hemorrhage volumes after brief periods of REBOA. 7, [10] [11] [12] As such, alternative techniques of achieving partial aortic occlusion (PAO) have been devised to off-load proximal pressure by permitting persistent low-volume distal blood flow through partial-REBOA (P-REBOA) or endovascular variable aortic control. 8, 13 In animal studies, P-REBOA improved proximal perfusion while minimizing the hypertension and excessive Q carotid seen with complete REBOA. 8, 9 Despite theoretical advantages of P-REBOA over complete REBOA for brain injured patients with NCTH, the impact of these techniques on brain injury has not been evaluated. 1, 8, 9 We hypothesized that the combined effects of increased proximal mean arterial pressure (pMAP), Q carotid , and ICP from REBOA would lead to traumatic brain injury (TBI) progression when compared with PAO or no intervention.
MATERIALS AND METHODS

Overview
The Institutional Animal Care and Use Committee at David Grant Medical Center, Travis Air Force Base, California approved this study. All animal care and use was in strict compliance with the Guide for the Care and Use of Laboratory Animals in a facility accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International. Healthy adult, castrate male, and nonpregnant female Yorkshirecross swine (Sus scrofa), obtained from the University of California, Davis, were acclimated for a minimum of 7 days. At the time of experimentation, animals weighed between 50 kg and 75 kg.
Conduct of the protocol, including animal preparation, injury, intervention, and postoperative critical care, is depicted in Figure 1 . After creation of a severe TBI, animals underwent controlled hemorrhage of 25% of total blood volume. After 30 minutes of sustained hypotension (prehospital phase), animals were randomized to 60 minutes of treatment with Zone 1 REBOA, PAO using a cable-driven automated aortic crossclamp (AAC) positioned in zone 1 allowing 300 mL/min of distal aortic flow, or no intervention (Control). Starting at 90 minutes, all animals were resuscitated with shed blood via a rapid blood infuser at a rate of 150 mL/min and graded restoration of systemic circulation was initiated using the AAC in the P-REBOA group and stepwise manual balloon deflation in the REBOA group. Subsequently, the animals entered an intensive care unit (ICU) phase during which all three groups were resuscitated to a defined goal (proximal MAP ≥70 mm Hg) in an effort to create a consistent degree of cerebral perfusion after intervention.
Animal Preparation
Animal preparation is described in detail in the supplemental methods content (see Methods, Supplemental Digital Content 1, http://links.lww.com/TA/A946). Briefly, animals were sedated, intubated, and anesthesia was then maintained on 2% isoflurane. An intravenous infusion of norepinephrine (0.01 μg/kg per hour) was titrated to achieve a target mean arterial pressure between 65 mm Hg and 75 mm Hg. Normal saline was administered at a rate of 5 mL/kg per hour to overcome insensible losses.
A 10-mm craniotomy was created adjacent to the left coronal suture for placement of an ICP-monitor (Codman Neuro, Raynham, MA). A second 20-mm craniotomy was performed in the right skull next to the sagittal and coronal sutures over the frontal lobe for preparation for controlled cortical impact. After cranial access was obtained, an arterial flow probe (Transonic Systems Inc., Ithaca, NY) was placed on the right carotid artery. Vascular access and monitoring has been previously described. 14, 15 A laparotomy and splenectomy were performed. The left hemidiaphragm was incised longitudinally and the supraceliac aorta was exposed. Two adjacent intercostal arteries were ligated, followed by placement of an aortic flow probe (Transonic Systems Inc., Ithaca, NY) as well as the variable AAC.
15-17 A 32-mm aortic occlusion balloon (ER-REBOA, Prytime Medical, Lakewood, CO) was positioned in the descending thoracic aorta through a 7F 13 cm introducer sheath (Cook Incorporated, Bloomington, IN) placed in the right femoral artery and confirmed via manual palpation.
Automated Aortic Clamp
To achieve tight control of distal aortic blood flow, our group devised a computer-controlled automated aortic clamp. This novel aortic occlusion apparatus represents an evolution from our previously described extracorporal variable aortic control device and was devised to facilitate animal preparation and the use of the computed tomography (CT) scanner. The device regulates downstream blood flow by variably opening and closing, thus providing varying degrees of aortic occlusion across the spectrum from full flow to complete occlusion. The clamp is capable of automatically and dynamically responding to changes in animal physiology, moving in sub-millimeter increments to achieve prescribed pressure or flow endpoints, which varied based on the phase and randomization arm of the experiment. To achieve this, the system utilized custom-designed algorithms that integrated input from the aortic flow probe and proximal pressure to determine the movement of the clamp in a closed-loop feedback mechanism.
Data Collection
Physiologic parameters and aortic flow measurements were collected in real time using a Biopac MP150 multichannel data acquisition system. Parameters measured included heart rate, blood pressure proximal and distal to the AAC, central venous pressure (CVP), core temperature, pulse oxygenation, ICP, and Q carotid . Animals underwent serial CT scans using a BodyTom CT scanner (Neurologica, Danvers, MA).
Injury
The skulls of the pigs were attached to a custom stereotactic frame that secured the head at 90 degrees of forward flexion (see Figures, Supplemental Digital Content 2 and 3, http://links. lww.com/TA/A947 and http://links.lww.com/TA/A948). The TBI was created with a computer-controlled cortical impact device (Custom Design and Manufacturing, Richmond, VA) mounted to the stereotactic frame. A 10-mm rounded polymer striking tip was used with a fixed velocity of 4.0 m/s, depth of 12 mm, and dwell time of 200 μs. A piezoelectric impact monitor (PCB Piezotronics, Depew, NY) embedded in the striking tip and connected to an oscilloscope (Silgent, Shenzhen, China) confirmed initial dural contact during alignment. After cortical impact, the nylon plug was repositioned into the craniotomy site to minimize leakage of CSF and eliminate artificial ICP readings.
After the TBI, hemorrhagic shock was created by withdrawing 25% of estimated blood volume (Body Weight (g) Â 0.06) through an arterial cannula into citrated blood collection bags over a 30-minute period.
Intervention
During the hemorrhagic shock phase, animals were randomized into one of three groups: Control, REBOA, and PAO. All animals that randomized to Control or PAO had their prepositioned REBOA catheters withdrawn before the onset of the intervention phase. Control animals were monitored without intervention throughout the subsequent 60 minutes. REBOA animals remained in complete occlusion for the 60-minute intervention phase. In the PAO arm, the ACC maintained a distal aortic flow rate between 150 mL/min to 300 mL/min according to a preprogrammed algorithm to achieve a proximal aortic MAP > 65. After 50 minutes of intervention animals were premedicated with 30 mL of 23% calcium gluconate (Agri Laboratories, St. Joseph, MO) to counteract the effects of citrate present in the transfused blood and stabilize the myocardium during reperfusion. At the end of the 60-minute intervention period all animals underwent resuscitation with previously shed whole blood. The occlusion balloon in REBOA animals was deflated at a rate of 0.5 mL/min until completely deflated. In the PAO group, the AAC autonomously weaned from occlusion as the proximal blood pressure allowed. All animals then entered the ICU phase.
ICU Phase
To evaluate the delayed effects of the intervention itself on TBI progression without subsequent hemodynamic compromise confounding the study, the AAC was then activated in all three groups to maintain equivalent proximal blood pressures throughout the 4-hour ICU phase. To minimize investigator bias during this phase of care computerized decision support algorithms automatically prompted providers to administer crystalloids and titrate vasopressors. Animals received 500 mL fluid boluses if the CVP was less than 6 mm Hg and norepinephrine was increased by 0.01 μg/kg per hour every 15 minutes if the ACC was active. During refractory hypotensive episodes, the AAC maintained proximal pressure until intravenous fluids and/or vasopressors were effective in maintaining a proximal MAP greater than 65 mm Hg. Physiologic parameters were recorded continuously, laboratory analysis was obtained at predefined intervals, and brain CT imaging was obtained at T0, T40, T80, T180, and T360. Electrolyte abnormalities including hyper-and hypoglycemia were corrected throughout the ICU phase. Animals were humanely euthanized at the end of study.
Data Analysis
Brain injury was quantified on non-contrasted CT of the area of injury. A neuroradiologist blinded to intervention provided volumetric analysis of the injury using the ABC/2 method. 18 The presence of subarachnoid hemorrhage, epidural hemorrhage, and or subdural hemorrhage was confirmed at necropsy immediately after euthanasia.
The primary outcome measure was the size of TBI observed on serial CT scans. This was analyzed using analysis of variance for the discreet timepoints noted previously (the CT scan intervals and end of study). Post hoc pairwise comparisons were performed when indicated. Data were entered into Excel datasheets (Microsoft Corporation) and transferred to STATA version 14.0 (Stata Corporation, Bryan, TX) for analysis. Continuous variables are presented as means and standard errors of the means (SEMs) if normally distributed and as medians with interquartile ranges if not distributed normally. Statistical significance was set at p less than 0.05.
RESULTS
Baseline physiology was similar between the groups ( Table 1 ). After 30 minutes of hypotension, there were no differences in mean arterial pressure (MAP). During the 60-minute intervention period, REBOA resulted in higher maximal MAP when compared to Control (REBOA, 105.3 ± 8.8 mm Hg; PAO, 92.7 ± 9.2 mm Hg; Control, 48.9 ± 8.87.7 mm Hg; p < 0.05). REBOA resulted in the highest Q carotid when compared with PAO and Control (REBOA, 673.1 ± 57.9 mL/min; PAO, 408.5 ± 38.3 mL/min; Control, 170.3 ± 29.4 mL/min; p < 0.01). There were no differences in maximal change in ICP or average change in ICP between any of the groups during the intervention phase (maximal change, p = 0.49; average change, p = 0.26). Cerebral perfusion pressure was below critical thresholds (60 mm Hg) during the intervention phase for Control animals (27.4 ± 5.5 mm Hg), but was significantly increased in both REBOA animals (67.6 ± 6.3 mm Hg) and PAO animals (66.2 ± 5.7 mm Hg) when compared with the hypotensive phase (see Figure C , Supplemental Digital Content 4, http://links.lww.com/TA/A949). On average, PAO resulted in higher CVP during the intervention phase when compared to Fig. 2D ). During the resuscitation phase, Control animals had the highest maximal MAP when compared with REBOA (Control, 97.3 ± 6.7 mm Hg; REBOA, 79.2 ± 1.6 mm Hg; p = 0.02) and PAO (PAO, 81.2 ± 1.7 mm Hg; p = 0.04). REBOA animals had the lowest maximal increase in ICP when compared with Control animals (REBOA, 5.1 ± 0.6 mm Hg; Control, 12.8 ± 1.2 mm Hg; p < 0.01) and PAO animals (PAO, 9.4 ± 1.1 mm Hg; p = 0.02). Although CVP was increased in all animals when compared with baseline (Fig. 2D) , there were no statistical differences in CVP during the resuscitation phase (Table 1) .
Within groups, Control and PAO animals experienced the highest ICP during the resuscitation phase when compared with the earlier intervention phase (Fig. 2C , Control p < 0.01, PAO p < 0.01), whereas the REBOA animals had similar ICP increases during intervention and resuscitation (Fig. 3C , Table 1 ).
The ICU phase of the experiment was designed to minimize proximal physiologic differences between groups by augmenting proximal aortic pressure to optimize flow to proximal vascular beds. From 90 minutes until the end of the experiment, the AAC ensured there were no differences in proximal MAP between the groups (Fig. 3A , p = 0.06). To achieve equivalent proximal MAPs, REBOA animals received more assistance from the AAC and thus, less distal aortic flow during the ICU phase when compared with Control and PAO animals (REBOA, 1,465 ± 400 mL/min, Control 2,540 ± 173 mL/min, PAO 2,407 ± 127 mL/min, Fig. 3B ). Overall, there were no differences in the change in ICP (Fig. 3C, p = 0.29) between all three groups throughout the critical care phase of the experiment. However, average CPP was significantly lower in REBOA animals when compared with PAO animals (Table 1 Laboratory values for lactate, pH, PCO 2 , and potassium are depicted in Figure 4 . Lactate peaked in the REBOA animals at 140 minutes, whereas the peak lactate for PAO animals occurred at 120 minutes. REBOA animal had increased lactate when compared to Control and PAO animals from 140 minutes until the end of the experiment. Lactate in PAO animals reached Control group levels starting at 240 minutes (Fig. 4A ). pH had a trend similar to lactate, with REBOA animals remaining acidotic when compared to Control and PAO animals from 120 minutes until the end of the experiment (Fig. 4B) . REBOA animals had a single period of hypocapnia at 50 minutes when compared with Control and PAO animals, with no other differences between groups for the remainder of the study (Fig. 4C) . Immediately after balloon deflation (95 minutes), REBOA animals had a single episode of hyperkalemia when compared with Control and PAO animals, with no further hyperkalemic episodes in any of the remaining blood draws in any of the groups (Fig. 4D ).
There were no statistically significant differences in the amount of fluids required by each group of animals (Control, 56 ± 17 mL/kg; REBOA, 64 ± 28 mL/kg; PAO, 48 ± 12 mL/ kg; p = 0.35). There were significant differences in the total cumulative dose of norepinephrine over the entirety of the experiment between groups (Control, 1.4 ± 0.6 μg/kg; REBOA, 3.1 ± 0.9 μg/kg; PAO, 2.9 ± 2.0 μg/kg, p = 0.05) but no significant differences within any group on post hoc analysis. There Table 2 ).
DISCUSSION
As use of REBOA increases, a better understanding of its effects in the multi-injured trauma patient is required. In the setting of TBI and shock, REBOA elevated Q carotid , proximal MAP, and ICP to supraphysiologic levels but did not cause radiographic evidence of TBI progression within this limited survival study. In contrast, PAO partially mitigated the development of intracranial hypertension and resulted in near-baseline Q carotid rates. Despite these findings, rapid blood resuscitation resulted in the largest increase in ICP for both Control animals and PAO animals.
Hypotension after TBI is known to be detrimental, yet there is increasing evidence that hypertension early after brain injury is also associated with poor outcomes. [19] [20] [21] [22] [23] [24] [25] Excessive blood pressure and blood flow to the brain may exacerbate a TBI by destabilizing intracerebral clots, promoting hemorrhage, and increasing cerebral edema. 24 In a propensity matched study from Japan, patients with head injury and low GCS were more likely to die if treated with REBOA. 7 Recent literature suggests a causal relationship, with at least one case report linking fatal TBI progression to REBOA. 12 Our findings support the many animal studies and clinical reports indicating that REBOA may result in supraphysiologic blood pressure and flow to proximal organs. 6, 8, 9, 26, 27 However, in this present study, the increased pMAP, Q carotid , and ICP in the REBOA group did not correlate with radiographic evidence of TBI progression during intervention or by the end of the study.
There are many possible explanations for this finding. It is possible that the ability of REBOA to elevate pMAP was sufficient to overcome the corresponding elevation in ICP, thereby maintaining cerebral perfusion pressure (CPP) and minimizing any exacerbation of the injury. A likely alternative explanation is that the CT findings in this limited survival study are only representative of the early resuscitation period after TBI and did not have an opportunity to fully develop. In clinical scenarios, 35% to 50% of patients with severe TBIs demonstrate progression over the initial 24 hours; therefore, it is plausible that the short time course for this study prevented observations of progression. 28, 29 Similarly, clinical studies of TBI victims emphasize that a lack of early radiographic progression is not predictive of outcomes. [30] [31] [32] Yet, elevated ICP is strongly associated with a fatal outcome after head trauma even when CPP is adequate. 33 Given the complex interplay of intracerebral pressure, blood flow, and hemorrhage volumes, future survival studies will be required to fully understand the effects of REBOA on TBI progression and mortality.
We also noted that supraphysiologic blood pressures were not maintained for the duration of the intervention in this TBI study. This finding stands in contrast to our prior work with a controlled hemorrhage model that demonstrated sustained increases in pMAP within the supraphysiologic range (>100 mm Hg) for the duration of the intervention. 8 In this combined TBI and hemorrhage model, proximal blood pressures were only maintained above 100 mm Hg for very brief periods, even though the degree of hemorrhage was the same between these experiments. This finding leads us to question whether the TBI had a direct, adverse effect on cardiac performance by effectively blunting the proximal hypertensive response previously demonstrated in other animal studies during sustained REBOA. Clinical studies of isolated, severe TBI have demonstrated that up to 25% of patients with isolated severe TBIs develop echocardiographic evidence of heart failure. 34, 35 Although it is difficult to directly compare the present experiment to clinical reports of heart failure in TBI, the relative inability of these brain-injured animals to produce the same supraphysiologic blood pressures seen in similar studies without TBI, does suggest the potential presence of TBI-induced cardiac dysfunction. 34, 35 Depending on the degree of shock, CPP augmentation by REBOA can range from appropriate to extreme. 26, 27 PAO delivered in a controlled manner may offer an alternative to decrease the risks associated with REBOA. Studies evaluating mild elevation of CPP by PAO in ischemic stroke patients found it to be safe even after treatment with thrombolytics. 36, 37 The baseline levels of Q carotid and smaller increases in ICP with PAO versus REBOA are consistent with other animal studies in NCTH models without TBI and in similar studies in euvolemic models. 8, 9, 38 The most unexpected observation was that the largest physiologic fluctuations of the entire study occurred during massive transfusion rather than during the period of aortic intervention. Massive transfusion has been identified as a predictor of mortality in many trauma studies, but elucidating an etiology is confounded by injury severity, variations in transfusion ratios, coagulopathy, and transfusion reactions. 39, 40 A retrospective analysis at a Level I trauma center observed that delivery of blood through a Rapid Infusion System resulted in greater than expected mortality, but was unable to discern a cause. 41 Our findings are consistent with other animal models that have shown worse outcomes with the combination of blood product administration and REBOA, more than either intervention in isolation. 26 The mechanism of this increase in ICP during blood resuscitation is likely multifactorial and may not be easily recognized during direct clinical care. Although an increase in MAP during blood resuscitation corresponded with an increase in ICP in the Control group, in both the REBOA and PAO groups, ICP increased during blood resuscitation despite an unchanged or decreasing MAP. This finding indicates that ICP increases may have resulted from rapid and dramatic increases in CVP brought on by the impaired venous drainage and venous return during rapid blood resuscitation. Although the ICP and CVP relationship is intriguing, future studies are required to identify the exact etiology of these ICP fluctuations. Nevertheless, the results from the resuscitation phase of the present study suggest that changes in ICP during a trauma resuscitation are not always readily apparent with current methods of hemodynamic monitoring. Appropriate resuscitation is reliant on the astute physician to understand the complex physiologic changes that can occur during massive transfusion. Further studies are needed to optimize fluid resuscitation and transfusion strategies in REBOA patients with respect to timing, rate, and volume of blood administered.
There are several limitations to our current model. First, there are inherent difficulties in studying TBI with an animal model. The term "traumatic brain injury" actually encompasses a wide array of injuries ranging from penetrating trauma, to intracranial hemorrhage, to diffuse axonal injury, and more. 42 Blast injury and motor vehicle collisions represent the most common mechanisms of combined NCTH and TBI in military and civilian populations, respectively. 43, 44 Although the controlled cortical impact model in this study created a reproducible injury that minimized variability and allowed for better scientific comparison within the study group, this injury is not necessarily analogous to the mechanisms of head injury seen in multisystem trauma patients. It is not known whether different types of brain injury respond differently to acute variations in cerebral perfusion. Unfortunately, this vital question remains unanswered by our study. Additionally, our study was limited to the immediate effects of intervention as we not able to perform prolonged survival studies. It is possible that more time is needed to observe quantifiable progression of brain injury on a CT scan.
Differentiating the effects of proximal hypertension during intervention from the effects of reperfusion can guide the development of new occlusion devices and resuscitation strategies. To isolate the variable of interest (proximal blood pressure during intervention), the proximal blood pressure was tightly regulated during the ICU phase by application of the AAC. Since the degree of blood pressure support needed to maintain equivalent proximal MAPs during the ICU phase varied between animals, each required a different degree of supportive AAC. The REBOA animals in particular required more blood pressure support than animals in other groups. This finding may indicate the presence of refractory hypotension or blood pressure variability in the absence of ACC in this group. Rebound hypotension, reperfusion injury, and myocardial depression after REBOA are well documented, particularly after intervention times in excess of 40 minutes. All of these variables may worsen TBI after REBOA. Currently REBOA is limited to resource rich environments capable of rapid surgical intervention to minimize occlusion times. We have previously demonstrated that PAO with low-volume permissive regional hypoperfusion distal to zone 1 allows for prolonged intervention times up to 90 minutes in a uniformly lethal liver injury model, while promoting lactate clearance after only several hours of critical care. This work has further strengthened the case for PAO as a viable alternative to complete occlusion. Continued refinements of PAO mechanisms, including techniques, such as P-REBOA and Endovascular Variable Aortic Control, are required to allow carefully titrated partial occlusion to advance beyond an experimental concept to a therapeutic reality. In that light, our group is designing future studies to examine the effects of REBOA and purpose-specific P-REBOA endovascular catheters on TBI as they would be used clinically, without subsequent mechanical blood pressure support to counter rebound hypotension.
These future TBI studies should include longer study durations, advanced neuroimaging, and additional quantification of brain injury with histologic and chemical markers of neuronal damage.
CONCLUSION
In the setting of TBI and shock, REBOA elevated Q carotid , pMAP, and ICP but did not cause radiographic progression of TBI. PAO resulted in baseline levels of blood flow to the head and systemic BP with smaller increases of ICP during intervention than REBOA. Moreover, rapid blood resuscitation, and not REBOA, resulted in the largest increase in ICP after intervention. Continued studies of the cerebral hemodynamics of aortic occlusion and blood transfusion are required to determine optimal resuscitation strategies for multi-injured patients. AUTHORSHIP M.J., T.W., and L.N. conceived of the study, executed the study, and drafted and critically reviewed the article. M.J. and J.G. conducted the data analysis and statistical analysis. S.F., A.D., R.R., T.R., J.G., and W.O. assisted in execution of the study and critically reviewed the article.
ACKNOWLEDGMENTS
We thank SSG Kelly Caneen, Mr. Carl Gibbins, Mr. Oren Gotlib, and Ms. Sally Knode, SSgt Elaine Spotts, SrA Geoffrey O'Hair, SSgt Vanessa Lang, and LtCol Robin Mitchell for their outstanding technical assistance, and the other staff of the Clinical Investigations Facility David Grant Medical Center for their support. We also extend thanks for Maj. Joel Dendulk, MSgt Timothy Fiol, and Mr. Jeffrey Sauerwein of the 60th Metals and Fabrication Shop, Travis AFB for their expertise in the design and fabrication of the stereotactic frame for the cortical impactor.
DISCLOSURE
Conflicts of Interest and Sources of Funding: There are no personal conflicts of interest. Dr. Johnson is the recipient of a training grant from the National Heart, Lung and Blood Institute: K12HL108964. This project was partly supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR000002 and TL1 TR000133. The Clinical Investigation Facility, David Grant Medical Center, Travis Air Force Base, California provided funding for this study. The animals involved in this study were procured, maintained, and used in accordance with the Laboratory Animal Welfare Act of 1966, as amended, and NIH 80-23, Guide for the Care and Use of Laboratory Animals, National Research Council.
